Premium
Repare Therapeutics Inc (RPTX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Show more
Realigning resources to extend runway to mid-2027 Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (Polθ ATPase inhibitor), with initial clinical readouts expected beginning...
Heavily-pretreated patients on lunresertib and camonsertib combination achieved 25.9% overall response rate (ORR) in endometrial cancer and 37.5% in platinum-resistant ovarian cancer Nearly half...
Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.01 | 0.719424460432 | 1.39 | 1.48 | 1.23 | 693454 | 1.36023873 | CS |
| 4 | -0.42 | -23.0769230769 | 1.82 | 1.83 | 1.2 | 693913 | 1.35460103 | CS |
| 12 | -2.04 | -59.3023255814 | 3.44 | 4.0695 | 1.2 | 419407 | 2.08238686 | CS |
| 26 | -2.09 | -59.8853868195 | 3.49 | 4.29 | 1.2 | 253119 | 2.40927873 | CS |
| 52 | -5.21 | -78.8199697428 | 6.61 | 8.49 | 1.2 | 222279 | 3.29627035 | CS |
| 156 | -13.72 | -90.7407407407 | 15.12 | 18.68 | 1.2 | 248787 | 8.8980209 | CS |
| 260 | -30.65 | -95.631825273 | 32.05 | 46.44 | 1.2 | 216931 | 13.88214003 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
